Home > Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer’s Disease Patients
Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer’s Disease Patients
Manuscript Number:
16-0216R2
Author(s):
H. Michael Arrighi, Frederik Barkhof, Jennifer Bogert, H. Robert Brashear, Jianing Di, Achim Gass, Nzeera Ketter, Yves Miaux, Derk D. Purcell
